GSC
PLXP

Ground Swell Capital’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Ground Swell Capital’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-208,998
Closed -$27.2K – 104
2023
Q1 		$27.2K Sell
208,998
-9,822
-4% -$2K 0.05% 34
2022
Q4 		$35.9K Buy
218,820
+176,311
+415% +$73.8K 0.16% 47
2022
Q3 		$28K Sell
42,509
-6,422
-13% -$9.46K 0.08% 78
2022
Q2 		$119K Buy
48,931
+17,781
+57% +$49.4K 0.22% 92
2022
Q1 		$126K Sell
31,150
-5,257
-14% -$28.8K 0.32% 43
2021
Q4 		$292K Buy
36,407
+6,221
+21% +$72.9K 1.7% 20
2021
Q3 		$583K Buy
+30,186
New +$528K 2.51% 7
2014
Q3 		– Sell
-76
Closed -$6K – 2859
2014
Q2 		$6K Buy
+76
New +$5.91K 0.01% 1017

Other funds holding PLXP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Ground Swell Capital's PLXP Position: Q2 2023 in Review

Ground Swell Capital sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 208,998 shares — an estimated $27.2K sold.

Ground Swell Capital first reported a position in PLXP in Q2 2014 and held it in 8 quarters. The position peaked at $583K in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • Ground Swell Capital reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ground Swell Capital sold 208,998 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $27.2K.
  • Ground Swell Capital first reported a position in PLx Pharma Inc. Common Stock in Q2 2014 and held it in 8 quarters.
  • Ground Swell Capital's PLx Pharma Inc. Common Stock position peaked at $583K in Q3 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Ground Swell Capital's 13F filing for Q2 2023, filed 10 Aug 2023.